188 filings
Page 3 of 10
6-K
sjb61m6 vo
5 Sep 23
NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officer
4:15pm
6-K
sos61af
31 Aug 23
NANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment Conference
4:15pm
6-K
0p6r0jv6mea2qyk0
15 Aug 23
Current report (foreign)
4:15pm
6-K
ltljqx
4 Aug 23
NANOBIOTIX to Host Extraordinary General Meeting of Shareholders on September 1st, 2023
4:15pm
6-K
eu9e1ta k7ypbe18hvm2
20 Jul 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
aofy 7im3rogt4ju7i
19 Jul 23
Current report (foreign)
4:15pm
6-K
vg4zjdq
10 Jul 23
NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3
6:05am
S-8
howpx5lu19iolgk37h3
27 Jun 23
Registration of securities for employees
8:19am
6-K
vpq0swevdctdsq 8hueh
8 Jun 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
7vfknxhib6 amneu5
17 May 23
NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update
4:15pm
6-K
kj7fg
5 May 23
Current report (foreign)
6:00am
6-K
ola4jr5de
24 Apr 23
NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results
7:55pm
6-K
w1i9s40eyfc
17 Apr 23
Current report (foreign)
4:18pm
6-K
qvg6h
11 Apr 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
1dwyq2cxz6i 76g6xzci
27 Mar 23
Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call
4:15pm
6-K
xdf70geg
14 Mar 23
Current report (foreign)
4:15pm
6-K
wp3 iig03bgb
14 Feb 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
jha qt2ausm6rmo7avk
11 Jan 23
Voting Rights and Shares Capital of the Company
5:15pm
6-K
ox69ofo4x b5
27 Dec 22
Current report (foreign)
6:05am